Cite
HARVARD Citation
Makimoto, G. et al. (2021). A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R. Japanese journal of clinical oncology. pp. 956-965. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Makimoto, G. et al. (2021). A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R. Japanese journal of clinical oncology. pp. 956-965. [Online].